Patent Yard Sign in
Canadian application, no grantCanada

Methods of treating gastrointestinal and genitourinary pain disorders using venlafaxine and derivatives

CA 2485736 A1 · Owner: Danilewitz, Mervyn · Inventors: Lynn, Richard Brian; Karlstadt, Robyn Gail; Burton, Michael Scott

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

This invention provides a method of treating functional gastrointestinal and genitourinary disorders in a mammal by administering to the mammal an effective amount of hydroxycycloalkane phenethylamine of the following structural formula (I) in which A is a moiety of the formula (II) where the dotted line represents optional unsaturation; R1 is hydrogen or alkyl; R2 is alkyl; R4 is hydrogen, alkyl, formyl, or alkanol; R5 and R6 are independently, hydrogen, hydroxyl, alkyl alkoxy, alkanoyloxy, cyano, nitro, alkylmercapto amino, alkylamino, dialkylamino, alkanamido halo, trifluoromethyl, or taken together methylene dioxy; R7 is hydrogen or alkyl; and n is 0, 1, 2, 3, or 4, or a …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 15, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 15, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 15, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 15, 2003
GrantedNo grant recorded
Term endedMay 15, 2023
Patent numberCA 2485736 A1
Classification (IPC)A61K31/13 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedMay 15, 2003Term endedMay 15, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.